Citation: M. Telatar et al., Detection of bcl-2/IgH rearrangements by quantitative-competitive PCR and capillary electrophoresis, MOL DIAGN, 6(3), 2001, pp. 161-168
Citation: S. Alas et al., Inhibition of interleukin 10 by Rituximab results in down-regulation of Bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis, CLIN CANC R, 7(3), 2001, pp. 709-723
Authors:
Winston, DJ
Emmanouilides, C
Kroeber, A
Hindler, J
Bruckner, DA
Territo, MC
Busuttil, RW
Citation: Dj. Winston et al., Quinupristin/dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium, CLIN INF D, 30(5), 2000, pp. 790-797
Authors:
Stiff, P
Gingrich, R
Luger, S
Wyres, MR
Brown, RA
LeMaistre, CF
Perry, J
Schenkein, DP
List, A
Mason, JR
Bensinger, W
Wheeler, C
Freter, C
Parker, WRL
Emmanouilides, C
Citation: P. Stiff et al., A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma, BONE MAR TR, 26(5), 2000, pp. 471-481
Citation: S. Alas et al., Potentiation of fludarabine cytotoxicity on non-Hodgkin's lymphoma by pentoxifylline and Rituximab, ANTICANC R, 20(5A), 2000, pp. 2961-2966
Authors:
Wiseman, GA
White, CA
Witzig, TE
Gordon, LI
Emmanouilides, C
Raubitschek, A
Janakiraman, N
Gutheil, J
Schilder, RJ
Spies, S
Silverman, DHS
Grillo-Lopez, AJ
Citation: Ga. Wiseman et al., Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with Zevalin, a Y-90-labeled anti-CD20 monoclonal antibody, CLIN CANC R, 5(10), 1999, pp. 3281S-3286S
Authors:
Witzig, TE
White, CA
Wiseman, GA
Gordon, LI
Emmanouilides, C
Raubitschek, A
Janakiraman, N
Gutheil, J
Schilder, RJ
Spies, S
Silverman, DHS
Parker, E
Grillo-Lopez, AJ
Citation: Te. Witzig et al., Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsedor refractory CD20(+) B-cell non-Hodgkin's lymphoma, J CL ONCOL, 17(12), 1999, pp. 3793-3803
Authors:
Emmanouilides, C
Rosen, P
Rasti, S
Territo, B
Kunkel, L
Citation: C. Emmanouilides et al., Treatment of indolent lymphoma with fludarabine/mitoxantrone combination: A phase II trial, HEMATOL ONC, 16(3), 1998, pp. 107-116